Altered expression of sulfotransferases, glucuronosyltransferases and mrp transporters in FVB/mrp1–/– mice

References

• ANDERSON, M. E., 1985, Determination of glutathione and glutathione disulfide in biological samples. Methods in Enzymology, 113, 548–555.
   PubMed Web of Science ®Google Scholar
• BALDWIN, W. S. and LEBLANC, G. A., 1992, The anti-carcinogenic plant compound indole-3-carbinol differentially modulates P450-mediated steroid hydroxylase activities in mice. Chemico-Biological Interactions, 83, 155–169.
   PubMedGoogle Scholar
• BELINSKY, M. G., BAIN, L. J., BALSARA, B. B., TESTA, J. R. and KRUH, G. D., 1998, Characterization of MOAT-C and MOAT-D new members of the MRP/cMOAT subfamily of transporter proteins. Journal of the National Cancer Institute, 90, 1735–1741.
   Google Scholar
• BOCK, K. W., GSCHAIDMEIER, H., HEEL, H., LEHMKOSTER, T., MUNZEL, P. A., RASCHKO, F. and BOCK-HENNING, B., 1998, AH receptor-controlled transcriptional regulation and function of rat and human UDP-glucuronosyltransferase isoforms. Advances in Enzyme Regulation, 38, 207–222.
   Google Scholar
• BORST, P., EVERS, R., KooL, M. and WIJNHOLDS, J., 1999, The multidrug resistance protein family. Biochimica et Biophysica Acta, 1461, 347–357.
   PubMed Web of Science ®Google Scholar
• BRADFORD, M. M., 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein dye binding. Analytical Biochemistry, 72, 248–254.
   PubMed Web of Science ®Google Scholar
• CHEN, Z.-S., MUTOH, M., SUMIZAWA, T., FURUKAWA, T., HARAGUCHI, M., TANI, A. and AKIYAMA, S., 1997, Reversal of heavy metal resistance in multidrug-resistant human KB carcinoma cells. Biochemical and Biophysical Research Communications, 236, 586–590.
   Google Scholar
• COFFMAN, B. L., Rios, G. R. and TEPHLY, T. R., 1999, Measurements of UDP-glucuronosyltransferase (UGT) activities. Current Protocols in Toxicology, 4.3, 4.3.1–4.3.15.
   Google Scholar
• ENOMOTO, A., Prox, K., NAGAYOSHI, E., HARUTA, J., KIMURA, T., O'CONNOR, T., HARADA, T. and YAMAMOTO, M., 2001, High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicological Sciences, 59, 169–177.
   Google Scholar
• FLENS, M. J., ZAMAN, G. J. R., VAN DER VALK, P., IZQUIERDO, M. A., SCHROEIJERS, A. B., SCHEFFER, G. L., VAN DER GROEP, P., DE HAAS, M., MEIJER, C. J. L. M. and SCHEPER, R. J., 1996, Tissue distribution of the multidrug resistance protein. American Journal of Pathology, 148, 1237–1247.
   Google Scholar
• GRANCHAROV, K., NAYDENOVA, Z., LOZEVA, S. and GOLOVINSKY, E., 2001, Natural and synthetic inhibitors of UDP-glucuronosyltransferase. Pharmacology and Therapeutics, 89, 171–186.
   PubMed Web of Science ®Google Scholar
• HABIG, W. H., PABST, M. J. and JAKosv, W. B., 1974, Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry, 249, 7130–7139.
   PubMed Web of Science ®Google Scholar
• HIROHASHI, T., SUZUKI, H., ITo, K., OGAWA, K., KUME, K., SHIMIZU, T. and SUGIYAMA, Y., 1998, Hepatic expression of multidrug resistance-associated protein-like proteins maintained in Eisai hyperbilirubinemic rats. Molecular Pharmacology, 53, 1068–1075.
   PubMed Web of Science ®Google Scholar
• HIROHASHI, T., SUZUKI, H., TAKIKAWA, J. and SUGIYAMA, Y., 2000, ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (mrp3). Journal of Biological Chemistry, 275, 2905–2910.
   PubMed Web of Science ®Google Scholar
• HUANG, W., ZHANG, J., CHUA, S. S., QATANANI, M., HAN, Y., GRANATA, R. and MOORE, D. D., 2003, Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proceedings of the National Academy of Sciences, USA, 100, 4156–4161.
   PubMed Web of Science ®Google Scholar
• JEDLITSCHKY, G., LEIER, I., BUCHHOLZ, U., HUMMEL-EISENBEISS, J., BURCHELL, B. and KEPPLER, D., 1997, ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochemical Journal, 327, 305–310.
   Google Scholar
• KONIG, J., NIES, A. T., Cm, Y., LEIER, I. and KEPPLER, D., 1999a, Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochimica et Biophysica Acta, 1461, 377–394.
   PubMed Web of Science ®Google Scholar
• KONIG, J., ROST, D., Cm, Y. and KEPPLER, D., 1999b, Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology, 29, 1156–1163.
   PubMed Web of Science ®Google Scholar
• KRUH, G. D., ZENG, H., REA, P. A., Liu, G., CHEN, Z.-S., LEE, K. and BELINSKY, M. G., 2001, MRP subfamily transporters and resistance to anticancer agents. Journal of Bioenergetics and Biomembranes, 33, 493–501.
   Google Scholar
• LEE, K., BELINSKY, M. G., BELL, D. W., TESTA, J. R. and KRUH, G. D., 1998, Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter. Cancer Research, 58, 2741–2747.
   PubMed Web of Science ®Google Scholar
• LOE, D. W., ALMQUIST, K. C., DEELEY, R. G. and COLE, S. P. C., 1996, Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Journal of Biological Chemistry, 271, 9675–9682.
   PubMed Web of Science ®Google Scholar
• LOE, D. W., DEELEY, R. G. and COLE, S. P., 1998, Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. Cancer Research, 58, 5130–5136.
   PubMed Web of Science ®Google Scholar
• LORICO, A., RAPPA, G., FINCH, R. A., YANG, D., FLAVELL, R. A. and SARTORELLI, A. C., 1997, Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Research, 57, 5238–5242.
   PubMed Web of Science ®Google Scholar
• PAULUSMA, C. C., KOOL, M., BOSMA, P. J., SCHEFFER, G. L., TER BORG, F., SCHEPER, R. J., TYTGAT, G. N., BORST, P., BAAS, F. and OUDE ELFERINK, R. P., 1997, A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin—Johnson Syndrome. Hepatology, 25, 1539–1542.
   PubMed Web of Science ®Google Scholar
• PEI, Q.-L., KOBAYASHI, Y., TANAKA, Y., TAGUCHI, Y., HIGUCHI, K., KAITO, M., MA, N., SEMBA, R., KAmismco, T. and ADACHI, Y., 2002, Increased expression of multidrug resistance-associated protein 1 (mrpl) in hepatocyte basolateral membrane and renal tubular epithelia after bile duct ligation in rats. Hepatology Research, 22, 58–64.
   PubMed Web of Science ®Google Scholar
• PENG, K.-C., CLUZEAUD, F., BENS, M., VAN HUYEN, J. P., WIOLAND, M. A., LACAVE, R. and VANDEWALLE, A., 1999, Tissue and cell distribution of the multidrug resistance-associated protein (MRP) in mouse intestine and kidney. Journal of Histochemistry and Cytochemistry, 47, 757–768.
   Google Scholar
• PETERS, W. H. M., JANSEN, P. L. M. and NAUTA, H., 1984, The molecular weights of UDP-glucuronyltransferase determined with radiation-inactivation analysis. Journal of Biological Chemistry, 259, 11701–11705.
   Google Scholar
• RUNGE-MORRIS, M., 1998, Regulation of sulfotransferase gene expression by glucocorticoid hormones and xenobiotics in primary rat hepatocyte culture. Chemico-Biological Interactions, 109, 315–327.
   Google Scholar
• RUNGE-MORRIS, M., ROSE, K., FALANY, C. N. and KOCAREK, T. A., 1998, Differential regulation of individual sulfotransferase isoforms by phenobarbital in male rat liver, Drug Metabolism and Disposition, 26, 795–801.
   Google Scholar
• SCHUETZ, E. G., STROM, S., YASUDA, K., LECUREUR, V., ASSEM, M., BRIMER, C., LAMBA, J., KIM, R. B., RAMACHANDRAN, V., KOMOROSKI, B. J., VENKATARAMANAN, R., CAI, H., SINAL, C. J., GONZALEZ, F. J. and SCHUETZ, J. D., 2001, Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. Journal of Biological Chemistry, 276, 39411–39418.
   PubMed Web of Science ®Google Scholar
• SCHUETZ, E. G., UMBENHAUER, D. R., YASUDA, K., BRIMER, C., NGUYEN, L., RELLING, M. V., SCHUETZ, J. D. and SCHINKEL, A., 2000, Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdrl genes. Molecular Pharmacology, 57, 188–197.
   PubMed Web of Science ®Google Scholar
• SHENG, J. J., SHARMA, V. and DUFFEL, M. W., 2001, Measurement of aryl and alcohol sulfotransferase activity. Current Protocols in Toxicology, 4.5, 4.5.1–4.5.9.
   Google Scholar
• SONODA, J., XIE, W., ROSENFELD, J. M., BARWICK, J. L., GUZELLAN, P. S. and EVANS, R. M., 2002, Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proceedings of the National Academy of Sciences, USA, 99, 13801–13806.
   PubMed Web of Science ®Google Scholar
• STRASSER, S. I., MASHFORD, M. L. and DESMOND, P. V., 1998, Regulation of uridine diphosphate glucuronosyltransferase during the acute-phase response, Journal of Gastroenterology and Hepatology, 13, 88–94.
   Google Scholar
• THIEBAUT, F., TSURUO, T., HAMADA, H., GOTTESMAN, M. M., PASTAN, I. and WILLINGHAM, M. C., 1987, Cellular localization of the multidrug resistance gene product in normal human tissues. Proceedings of the National Academy of Sciences, USA, 84, 7735–7738.
   PubMed Web of Science ®Google Scholar
• TRIBULL, T. E., BRUNER, R. H. and BAIN, L. J., 2003, The multidrug resistance-associated protein 1 (MRP1/ABCC1) transports methoxychlor and protects the seminiferous epithelium from injury. Toxicology Letters, 142, 61–70.
   PubMed Web of Science ®Google Scholar
• WAXMAN, D. J., Ko, A. and WALSH, C., 1983, Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P450 isozymes purified from phenobarbital-induced rat liver. Journal of Biological Chemistry, 258, 11937–11947.
   PubMed Web of Science ®Google Scholar
• WIJNHOLDS, J., EVERS, R., VAN LEUSDEN, M. R., MOL, C. A. A. M., ZAMAN, G. J. R., MAYER, U., BEIJNEN, J. H., VAN DER VALK, M., KRIMPENFORT, P. and BORST, P., 1997, Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nature Medicine, 3, 1275–1279.
   Google Scholar
• WIJNHOLDS, J., MOL, C. A. A. M., VAN DEEMTER, L., DE HAAS, M., SCHEFFER, G. L., BAAS, F., BEIJNEN, J. H., SCHEPER, R. J., HATSE, S., DE CLERCQ, E., BALZARINI, J. and BORST, P., 2000, Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nuclotide analogs. Proceedings of the National Academy of Sciences, USA, 97, 7476–7481.
   Google Scholar
• WIJNHOLDS, J., SCHEFFER, G. L., VANDER VALK, M., VAN DER VALK, P., BEIJNEN, J. H., SCHEPER, R. J. and BORST, P., 1998, Multidrug resistance protein 1 protects the oropharyngeal mucosal layer and the testicular tubules against drug-induced damage. Journal of Experimental Medicine, 188, 797–808.
   PubMed Web of Science ®Google Scholar
• XIE, W., YEUH, M.-F., RADOMINSKA-PANDYA, A., SAINT, S. P. S., NEGISHI, Y., BOTTROFF, B. S., CABRERA, G. Y., TUKEY, R. H. and EVANS, R. M., 2003, Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proceedings of the National Academy of Sciences, USA, 100, 4150–4155.
   Google Scholar